Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced neuropathies

A J Windebank1

  • 1Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

Bailliere'S Clinical Neurology
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Research details drug-induced neuropathies and their molecular causes. Future work will focus on neuroprotective agents to prevent nerve damage from chemotherapy drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechano growth factor interacts with nucleolin to protect against cisplatin-induced neurotoxicity.

Experimental neurology·2020
Same author

Dynamic role of kallikrein 6 in traumatic spinal cord injury.

The European journal of neuroscience·2006
Same author

Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis.

Neurology·2006
Same author

Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies.

Biomaterials·2003
Same author

Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy.

Journal of neurology, neurosurgery, and psychiatry·2002
Same author

Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo.

Neurobiology of disease·2001
Same journal

Remyelination in demyelinating disease.

Bailliere's clinical neurology·1999
Same journal

Other immunomodulatory therapies in multiple sclerosis.

Bailliere's clinical neurology·1999
Same journal

Copolymer-1.

Bailliere's clinical neurology·1999
Same journal

Interferon beta 1a.

Bailliere's clinical neurology·1999
Same journal

Treatment of multiple sclerosis with interferon beta 1b.

Bailliere's clinical neurology·1999
Same journal

The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis.

Bailliere's clinical neurology·1999
See all related articles

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Significant advancements in understanding drug-induced neuropathies over the last two decades.
  • Clinical manifestations of drug-induced neuropathies are well-documented.
  • Emerging research focuses on molecular mechanisms and therapeutic interventions.

Purpose of the Study:

  • To delineate the molecular mechanisms underlying drug-induced neuropathies.
  • To explore the potential of novel neuroprotective agents for preventing these conditions.
  • To highlight the ongoing importance of research in this field due to evolving treatment strategies.

Main Methods:

  • Review of existing literature on drug-induced neuropathies.
  • Analysis of molecular pathways involved in neurotoxicity.

Related Experiment Videos

  • Evaluation of neuroprotective strategies.

    • Main Results:

    • Comprehensive description of neurotoxic processes and clinical syndromes.
    • Identification of key molecular mechanisms driving nerve damage.
    • Potential therapeutic targets for neuroprotection identified.

    Conclusions:

    • Continued research is crucial, especially with the development of new neurotoxic drugs and combination therapies.
    • Findings may offer insights into non-drug-induced peripheral neurodegenerative disorders.
    • Development of effective neuroprotective agents is a key future direction.